We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

European Trial of Immunosuppression in SPK Tx

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00140543
Recruitment Status : Unknown
Verified August 2005 by EUROSPK Study Group.
Recruitment status was:  Active, not recruiting
First Posted : September 1, 2005
Last Update Posted : November 18, 2005
Fujisawa GmbH
Hoffmann-La Roche
Wyeth is now a wholly owned subsidiary of Pfizer
Neovii Biotech
Genzyme, a Sanofi Company
Information provided by:
EUROSPK Study Group

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Estimated Study Completion Date : April 2008